Skip to main content
Top
Published in: Inflammation 4-6/2005

01-12-2005

Leukocytes in Complex Regional Pain Syndrome Type I

Authors: Edward C. T. H. Tan, Wim J. G. Oyen, R. Jan A. Goris

Published in: Inflammation | Issue 4-6/2005

Login to get access

Abstract

Objective

The pathophysiology of Complex Regional Pain Syndrome type I (CRPS I) is unclear. An inflammatory reaction may cause the syndrome in which leukocytes may play an important role.

Materials and Methods

In this pilot study of six patients with acute warm CRPS I, we performed radiolabeled autologous leukocyte scans of both hands, in order to assess leukocyte accumulation. Comparison was made with the unaffected limb, and with three control patients with a Colles fracture without CRPS I.

Results

Images of the CRPS I patients obtained 4 h after leukocyte injection provided the clearest results. At 4 h post-injection, there was clear, asymmetrical leukocyte accumulation in the affected extremity with a mean ratio of 1.49±0.19. In control patients, no asymmetry was observed between hands (mean ratio 1.09±0.06), indicating the absence of specific leukocyte accumulation. There was a statistically significant difference between CRPS I and control subjects 4 h post injection (p=0.012).

Conclusion

We found a significantly increased accumulation of leukocytes in patients with CRPS I. This is the first study to show a possible role for leukocytes in the pathophysiology of acute CRPS I.
Literature
1.
go back to reference Sudeck, P. 1942. Die sogenannte akute Knochenatrophie als Entzündungsvorgang. Der Chirurg 15:449–458. Sudeck, P. 1942. Die sogenannte akute Knochenatrophie als Entzündungsvorgang. Der Chirurg 15:449–458.
2.
go back to reference Veldman, P. H., H. M. Reynen, I. E. Arntz, and R. J. Goris. 1993. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 342:1012–1016.PubMedCrossRef Veldman, P. H., H. M. Reynen, I. E. Arntz, and R. J. Goris. 1993. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 342:1012–1016.PubMedCrossRef
3.
go back to reference Oyen, W. J., I. E. Arntz, R. A. Claessens, J. W. van der Meer, F. H. Corstens, and R. J. Goris. 1993. Reflex sympathetic dystrophy of the hand: an excessive inflammatory response? Pain 55:151–157.PubMedCrossRef Oyen, W. J., I. E. Arntz, R. A. Claessens, J. W. van der Meer, F. H. Corstens, and R. J. Goris. 1993. Reflex sympathetic dystrophy of the hand: an excessive inflammatory response? Pain 55:151–157.PubMedCrossRef
4.
go back to reference Goris, R. J., L. M. Dongen, and H. A. Winters. 1987. Are toxic oxygen radicals involved in the pathogenesis of reflex sympathetic dystrophy? Free Radic. Res. Commun. 3:13–18.PubMed Goris, R. J., L. M. Dongen, and H. A. Winters. 1987. Are toxic oxygen radicals involved in the pathogenesis of reflex sympathetic dystrophy? Free Radic. Res. Commun. 3:13–18.PubMed
5.
go back to reference Huygen, F. J., A. G. De Bruijn, M. T. De Bruin, J. G. Groeneweg, J. Klein, and F. J. Zijlstra. 2002. Evidence for local inflammation in complex regional pain syndrome type 1. Mediat. Inflamm. 11:47–51.CrossRef Huygen, F. J., A. G. De Bruijn, M. T. De Bruin, J. G. Groeneweg, J. Klein, and F. J. Zijlstra. 2002. Evidence for local inflammation in complex regional pain syndrome type 1. Mediat. Inflamm. 11:47–51.CrossRef
6.
go back to reference Huygen, F. J., S. Niehof, F. J. Zijlstra, P. M. van Hagen, and P. L. van Daele. 2004. Successful treatment of CRPS 1 with anti-TNF. J. Pain Symptom Manage. 27:101–103.PubMedCrossRef Huygen, F. J., S. Niehof, F. J. Zijlstra, P. M. van Hagen, and P. L. van Daele. 2004. Successful treatment of CRPS 1 with anti-TNF. J. Pain Symptom Manage. 27:101–103.PubMedCrossRef
7.
go back to reference Atkins, R. M., T. Duckworth, and J. A. Kanis. 1990. Features of algodystrophy after Colles’ fracture. J. Bone Jt. Surg., Br. 72:105–110. Atkins, R. M., T. Duckworth, and J. A. Kanis. 1990. Features of algodystrophy after Colles’ fracture. J. Bone Jt. Surg., Br. 72:105–110.
8.
go back to reference van der Laan, L., and R. J. Goris. 1997. Sudeck’s syndrome. Was Sudeck right? Unfallchirurg. 100:90–99.PubMedCrossRef van der Laan, L., and R. J. Goris. 1997. Sudeck’s syndrome. Was Sudeck right? Unfallchirurg. 100:90–99.PubMedCrossRef
9.
go back to reference Peters A. M., H. J. Danpure, S. Osman, R. J. Hawker, B. L. Henderson, and H. J. Hodgson et al. 1986. Clinical experience with 99mTc–hexamethylpropylene–amineoxime for labelling leucocytes and imaging inflammation. Lancet 2:946–949.PubMedCrossRef Peters A. M., H. J. Danpure, S. Osman, R. J. Hawker, B. L. Henderson, and H. J. Hodgson et al. 1986. Clinical experience with 99mTc–hexamethylpropylene–amineoxime for labelling leucocytes and imaging inflammation. Lancet 2:946–949.PubMedCrossRef
10.
go back to reference Peters, A. M., M. E. Roddie, H. J. Danpure, S. Osman, G.P. Zacharopoulos, P. George et al. 1988. 99Tcm–HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes. Nucl. Med. Commun. 9:449–463.PubMedCrossRef Peters, A. M., M. E. Roddie, H. J. Danpure, S. Osman, G.P. Zacharopoulos, P. George et al. 1988. 99Tcm–HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes. Nucl. Med. Commun. 9:449–463.PubMedCrossRef
11.
go back to reference Hammersley, P. A., and A. T. Nkohkwo. 2001. Studies on white blood cell labelling: (99)Tc(m)–HMPAO preferentially labels granulocytes. Nucl. Med. Commun. 22:981–986.PubMedCrossRef Hammersley, P. A., and A. T. Nkohkwo. 2001. Studies on white blood cell labelling: (99)Tc(m)–HMPAO preferentially labels granulocytes. Nucl. Med. Commun. 22:981–986.PubMedCrossRef
12.
go back to reference Nussler, A. K., U. A. Wittel, N. C. Nussler, and H. G. Beger. 1999. Leukocytes, the Janus cells in inflammatory disease. Langenbeck’s Arch. Surg. 384:222–232.CrossRef Nussler, A. K., U. A. Wittel, N. C. Nussler, and H. G. Beger. 1999. Leukocytes, the Janus cells in inflammatory disease. Langenbeck’s Arch. Surg. 384:222–232.CrossRef
13.
go back to reference Hansen, P. R. 1995. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91:1872–1885.PubMed Hansen, P. R. 1995. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 91:1872–1885.PubMed
15.
go back to reference Granger, D. N., P. R. Kvietys, and M. A. Perry. 1993. Leukocyte–endothelial cell adhesion induced by ischemia and reperfusion. Can. J. Physiol. Pharm. 71:67–75.PubMed Granger, D. N., P. R. Kvietys, and M. A. Perry. 1993. Leukocyte–endothelial cell adhesion induced by ischemia and reperfusion. Can. J. Physiol. Pharm. 71:67–75.PubMed
16.
go back to reference Hernandez, L. A., M. B. Grisham, B. Twohig, K. E. Arfors, J. M. Harlan, and D. N. Granger. 1987. Role of neutrophils in ischemia–reperfusion-induced microvascular injury. Am. J. Physiol. 253:H699–H703.PubMed Hernandez, L. A., M. B. Grisham, B. Twohig, K. E. Arfors, J. M. Harlan, and D. N. Granger. 1987. Role of neutrophils in ischemia–reperfusion-induced microvascular injury. Am. J. Physiol. 253:H699–H703.PubMed
17.
go back to reference van der Laan, L., W. J. Oyen, E. C. Tan, A. A. Verhofstad, T. Hendriks, and R. J. Goris. 1999. A comparison of free radical-induced vascular and skeletal muscle damage in immunocompetent and neutropenic rats. J. Surg. Res. 82:346–352.PubMedCrossRef van der Laan, L., W. J. Oyen, E. C. Tan, A. A. Verhofstad, T. Hendriks, and R. J. Goris. 1999. A comparison of free radical-induced vascular and skeletal muscle damage in immunocompetent and neutropenic rats. J. Surg. Res. 82:346–352.PubMedCrossRef
18.
go back to reference Korthuis, R. J., D. N. Granger, M. I. Townsley, and A. E. Taylor. 1985. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ. Res. 57:599–609.PubMed Korthuis, R. J., D. N. Granger, M. I. Townsley, and A. E. Taylor. 1985. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ. Res. 57:599–609.PubMed
19.
go back to reference Smith, J. K., D. L. Carden, and R. J. Korthuis. 1991. Activated neutrophils increase microvascular permeability in skeletal muscle: role of xanthine oxidase. J. Appl. Physiol. 70:2003–2009.PubMed Smith, J. K., D. L. Carden, and R. J. Korthuis. 1991. Activated neutrophils increase microvascular permeability in skeletal muscle: role of xanthine oxidase. J. Appl. Physiol. 70:2003–2009.PubMed
20.
go back to reference Smith, J. K., M. B. Grisham, D. N. Granger, and R. J. Korthuis. 1989. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am. J. Physiol. 256:H789–H793.PubMed Smith, J. K., M. B. Grisham, D. N. Granger, and R. J. Korthuis. 1989. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am. J. Physiol. 256:H789–H793.PubMed
21.
go back to reference Zimmerman, B. J., M. B. Grisham, and D. N. Granger. 1988. Mechanisms of oxidant-mediated microvascular injury following reperfusion of the ischemic intestine. Basic Life Sci. 49:881–886.PubMed Zimmerman, B. J., M. B. Grisham, and D. N. Granger. 1988. Mechanisms of oxidant-mediated microvascular injury following reperfusion of the ischemic intestine. Basic Life Sci. 49:881–886.PubMed
22.
go back to reference Hartrick, C. T. 2002. Increased production of nitric oxide stimulated by interferon-gamma from peripheral blood monocytes in patients with complex regional pain syndrome. Neurosci. Lett. 323:75–77.PubMedCrossRef Hartrick, C. T. 2002. Increased production of nitric oxide stimulated by interferon-gamma from peripheral blood monocytes in patients with complex regional pain syndrome. Neurosci. Lett. 323:75–77.PubMedCrossRef
Metadata
Title
Leukocytes in Complex Regional Pain Syndrome Type I
Authors
Edward C. T. H. Tan
Wim J. G. Oyen
R. Jan A. Goris
Publication date
01-12-2005
Published in
Inflammation / Issue 4-6/2005
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-006-9015-x

Other articles of this Issue 4-6/2005

Inflammation 4-6/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.